These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38993556)
1. PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer. Huang C; Yang Y; Wang X; Chen S; Liu Z; Li Z; Tang X; Zhang Q Int J Biol Sci; 2024; 20(9):3570-3589. PubMed ID: 38993556 [No Abstract] [Full Text] [Related]
2. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
3. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1. Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235 [TBL] [Abstract][Full Text] [Related]
4. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance. Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA circSETD3 hampers cell growth, migration, and stem cell properties in bladder cancer through sponging miR-641 to upregulate PTEN. Tian Y; Gao P; Dai D; Chen L; Chu X; Mei X Cell Cycle; 2021 Aug; 20(16):1589-1602. PubMed ID: 34288821 [TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis. Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition. Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537 [TBL] [Abstract][Full Text] [Related]
8. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells. Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
10. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM. Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945 [TBL] [Abstract][Full Text] [Related]
11. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway. Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma. Cheng J; Zhang R; Yan M; Li Y BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028 [TBL] [Abstract][Full Text] [Related]
13. Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726 [TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer. Chang F; Li J; Sun Q; Wei S; Song Y Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543 [TBL] [Abstract][Full Text] [Related]
15. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
16. CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR-10-3p. Zhang K; Fan R; Zhao D; Liu P; Yang Z; Liu J; Zhang S; Rao S; Wang Y; Wan L Thorac Cancer; 2022 Apr; 13(7):934-946. PubMed ID: 35307984 [TBL] [Abstract][Full Text] [Related]
17. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p. Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis. Liu Y; Zhai R; Hu S; Liu J Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608 [TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548. Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266 [TBL] [Abstract][Full Text] [Related]
20. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer. Pang J; Ye L; Zhao D; Zhao D; Chen Q Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]